Paresis Acquired in the Intensive Care Unit
JAMA 288:2859-2867, De Jonghe,B.,et al, 2002
The Effect of Intensive Diabetes Therapy on Development & Progression of Neuropathy
The Diabetes Control & Compl Trial Res Gr, Ann Int Med 122:561-56895., , 1995
Effect of Intensive Diabetes Treatment on Nerve Conduction
Diabetes Control and Complication Trial (DCCT) Reserach Group, Ann Neurol 38:869-88095., , 1995
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Lead
Adams & Victors Principles of Neurology Chp 43, pg 1220, Ropper, A.H.,et al, 2014
Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012
Vascular Risk Factors and Diabetic Neuropathy
NEJM 352: 341-350, 408, Tesfaye, S., et al, 2005
AAC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Stroke 33:2337-2341, Pasternak,R.C.,et al, 2002
Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
The Prevention of Neurogenetic Disease
Arch Neurol 52:356-362, 3451995., Rosenberg,R.N.&Iannaccone,S.T., 1995
Natural History of Peripheral Neuropathy in Patients with Non-Insulin-Dependent Diabetes Mellitus
NEJM 333:89-94, Partanen,J.,et al, 1995
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
Does Improved Control of Glycemia Prevent or Ameliorate Diabetic Polyneuropathy? Comm on Health Care Issues
Am Neurol Assoc, Ann Neurol 19:288-2901986., , 1986